Sign in Subscribe
Pricing Policies

Pricing Policies

Timely insights into the evolving pricing framework and policy levers shaping market access for medical technologies throughout their life cycle.
Oct
11
NHSA Insurance Funding Expert Zheng Jie: Shifting from Excessive Price Reduction to Value-Based Procurement for China's Drug Pricing Dilemma

NHSA Insurance Funding Expert Zheng Jie: Shifting from Excessive Price Reduction to Value-Based Procurement for China's Drug Pricing Dilemma

At the 5th China Rare Disease Cooperation and Exchange Conference, Zheng Jie, the leader of the Insurance Funding Analysis Expert
3 min read
Aug
02
China Implements More Moderate and Predictable Price Reduction for Older NRDL-Negotiated Drugs

China Implements More Moderate and Predictable Price Reduction for Older NRDL-Negotiated Drugs

In late June, the National Healthcare Security Administration (NHSA) commenced the 2023 National Reimbursement Drug List (NRDL) Dynamic Update, aiming
4 min read